Artificial Natural Killer Cells for Specific Tumor Inhibition and Renegade Macrophage Re‐Education
Source abstract
Abstract
Abstract Natural killer (NK) cells can not only recognize and eliminate abnormal cells but also recruit and re‐educate immune cells to protect the host. However, the functions of NK cells are often limited in the immunosuppressive tumor microenvironment (TME). Here, artificial NK cells (designated as aNK) with minor limitations of TME for specific tumor killing and renegade macrophage re‐education are created. The red blood cell membrane (RBCM) cloaks perfluorohexane (PFC) and glucose oxidase (GOX) to construct the aNK. The aNK can directly kill tumor cells by exhausting glucose and generating hydrogen peroxide (H2O2). The generated H2O2 is also similar to cytokines and chemokines for recruiting immune cells and re‐educating survived macrophages to attack tumor cells. In addition, the oxygen‐carried PFC can strengthen the catalytic reaction of GOX and normalize the hypoxic TME. In vitro and in vivo experiments display that aNK with slight TME limitations exhibit efficient tumor inhibition and immune activation. The aNK will provide a new sight to treat tumor as the supplement of aggressive NK cells.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Immune Cell Function and Interaction · Immune cells in cancer · Phagocytosis and Immune Regulation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
The Institute for Advanced Studies Wuhan University Wuhan 430072 P. R. China
Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry Wuhan University Wuhan 430072 P. R. China
Funding
National Natural Science Foundation of China
References (54)
Show source-provided references
1. 10.1038/nrc.2015.510.1038/nrc.2015.5 ↗
2. 10.1146/annurev.immunol.23.021704.11552610.1146/annurev.immunol.23.021704.115526 ↗
3. 10.1038/nm.273110.1038/nm.2731 ↗
4. 10.1159/00032850510.1159/000328505 ↗
5. 10.1038/369031a010.1038/369031a0 ↗
6. 10.1111/j.1365-3083.2009.02366.x10.1111/j.1365-3083.2009.02366.x ↗
7. 10.1038/ni.312310.1038/ni.3123 ↗
8. 10.1038/ni88010.1038/ni880 ↗
9. 10.1016/j.it.2003.10.01210.1016/j.it.2003.10.012 ↗
10. 10.1021/acsnano.8b0529210.1021/acsnano.8b05292 ↗
11. 10.1093/glycob/cww01310.1093/glycob/cww013 ↗
12. 10.1016/j.atherosclerosis.2016.07.01110.1016/j.atherosclerosis.2016.07.011 ↗
13. 10.1073/pnas.100942810710.1073/pnas.1009428107 ↗
14. 10.1002/adma.20180439510.1002/adma.201804395 ↗
15. 10.1126/science.aao050510.1126/science.aao0505 ↗
16. 10.1021/mp100422810.1021/mp1004228 ↗
17. 10.1016/j.ccell.2017.02.00810.1016/j.ccell.2017.02.008 ↗
18. 10.1002/adma.20180332210.1002/adma.201803322 ↗
19. 10.1021/acsnano.8b0096710.1021/acsnano.8b00967 ↗
20. 10.1038/nrc323910.1038/nrc3239 ↗
21. 10.1093/intimm/dxu09510.1093/intimm/dxu095 ↗
22. 10.1016/j.febslet.2013.10.01510.1016/j.febslet.2013.10.015 ↗
23. 10.1038/leu.2013.27910.1038/leu.2013.279 ↗
24. 10.1016/j.jcyt.2016.10.00910.1016/j.jcyt.2016.10.009 ↗
25. 10.1002/smll.20190090310.1002/smll.201900903 ↗
26. 10.1016/j.bbamem.2006.02.01510.1016/j.bbamem.2006.02.015 ↗
27. 10.1089/ars.2011.396810.1089/ars.2011.3968 ↗
28. 10.1002/jcb.2468310.1002/jcb.24683 ↗
29. 10.1038/nature0811910.1038/nature08119 ↗
30. 10.1038/cddis.2011.9610.1038/cddis.2011.96 ↗
31. 10.1038/s41467-018-07197-810.1038/s41467-018-07197-8 ↗
32. 10.1021/acsnano.7b0253310.1021/acsnano.7b02533 ↗
33. 10.1002/adma.20180832510.1002/adma.201808325 ↗
34. 10.1039/C7CS00891K10.1039/C7CS00891K ↗
35. 10.1159/00047550110.1159/000475501 ↗
36. 10.1111/imr.1226610.1111/imr.12266 ↗
37. 10.1021/acs.nanolett.8b0356810.1021/acs.nanolett.8b03568 ↗
38. 10.1002/adma.20170142910.1002/adma.201701429 ↗
39. 10.1002/adma.20180558110.1002/adma.201805581 ↗
40. 10.1021/acsnano.7b0100610.1021/acsnano.7b01006 ↗
41. 10.1021/acs.nanolett.8b0272010.1021/acs.nanolett.8b02720 ↗
42. 10.1016/j.cell.2018.10.01410.1016/j.cell.2018.10.014 ↗
43. 10.1016/j.cell.2018.11.04810.1016/j.cell.2018.11.048 ↗
44. 10.1038/s41590-018-0292-y10.1038/s41590-018-0292-y ↗
45. 10.1038/nm.396510.1038/nm.3965 ↗
46. 10.1002/adma.20180200610.1002/adma.201802006 ↗
47. 10.1073/pnas.112162310910.1073/pnas.1121623109 ↗
48. 10.1038/nm.393110.1038/nm.3931 ↗
49. 10.1002/smll.20180112010.1002/smll.201801120 ↗
50. 10.1073/pnas.152003211210.1073/pnas.1520032112 ↗
51. 10.1038/nnano.2016.16810.1038/nnano.2016.168 ↗
52. 10.1038/s41551-018-0254-610.1038/s41551-018-0254-6 ↗
53. 10.1038/s41467-018-04999-810.1038/s41467-018-04999-8 ↗
54. 10.1021/acsnano.9b0299310.1021/acsnano.9b02993 ↗